Ying Xu

机构：Howard Hughes Medical Institute, Shandong University of Traditional Chinese Medicine, Guizhou University, University of California, San Francisco

发表论文 251 篇 · 总被引 4860 次 · h-index 30

代表论文

• A Novel RANKL/RANK Inhibitor IMB-R38 Inhibits Osteoporosis Through Regulating Bone Metabolism (2025 · International Journal of Molecular Sciences · 被引 3)
• Surgical treatment of giant phyllodes tumors of the breast: a series of rare cases (2025 · Frontiers in Oncology · 被引 3)
• Phenotypic pleiotropy of missense variants in human B cell confinement receptor P2RY8 (2025 · Cell Genomics · 被引 3)
• Discovery of a macrocyclic FAK inhibitor GZD-257 for treatment of glioblastoma (2025 · Bioorganic & Medicinal Chemistry Letters · 被引 2)
• First-in-human study of DGPR1008 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer in patients undergoing radical prostatectomy (2025 · Translational Andrology and Urology · 被引 2)
• Design, synthesis, and anti-glioblastoma multiforme evaluation of novel multikinase inhibitors via a cyclization strategy with potent FAK inhibition (2026 · European Journal of Medicinal Chemistry · 被引 1)